Breaking News

Valneva Names New Chief Scientific Officer & Executive Committee Member

Dr. Schuitemaker is an accomplished R&D leader.

Author Image

By: Charlie Sternberg

Associate Editor

Valneva SE, a specialty vaccine company, has appointed Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer (CSO) and Executive Committee member, effective June 3, 2024.   Thomas Lingelbach, CEO of Valneva, says, “Hanneke’s addition to our team represents an important step in further strengthening Valneva’s strategic leadership, especially as we continue to build our R&D portfolio beyond our advanced clinical programs against Lyme disease and the chikungunya virus. Innovation is a f...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters